Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila Annie Peters

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|March 14, 2008
Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysisSheila Annie Peters
Clinical Pharmacokinetics|March 14, 2008
Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profilesSheila Annie Peters
Clinical Pharmacokinetics|June 26, 2019
Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting ThemSheila Annie Peters, Hugues Dolgos
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2007
Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in ratSheila Annie Peters, Leif Hultin
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2019
A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a SurrogateQier Wu, Sheila Annie Peters
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 3, 2022
Utility of preclinical species for uncertainty assessment and correction of prediction of human volume of distribution using the Rodgers-Lukacova modelEva Sherbetjian, Sheila-Annie Peters, Carl Petersson
Current Opinion in Drug Discovery & Development|June 30, 2009
Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimizationSheila Annie Peters, Anna-Lena Ungell, Hugues Dolgos
Biopharmaceutics & Drug Disposition|February 3, 2017
A comparative evaluation of models to predict human intestinal metabolism from nonclinical dataEstelle Yau, Carl Petersson, Hugues Dolgos, et al.
Clinical Pharmacokinetics|February 8, 2023
Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?Jose David Gomez-Mantilla, Fenglei Huang, Sheila Annie Peters
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2012
Evaluation of the use of static and dynamic models to predict drug-drug interaction and its associated variability: impact on drug discovery and early developmentSheila Annie Peters, Patricia E Schroeder, Nagdeep Giri, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|March 14, 2008
Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysisSheila Annie Peters
Clinical Pharmacokinetics|March 14, 2008
Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profilesSheila Annie Peters
Clinical Pharmacokinetics|June 26, 2019
Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting ThemSheila Annie Peters, Hugues Dolgos
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2007
Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in ratSheila Annie Peters, Leif Hultin
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2019
A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a SurrogateQier Wu, Sheila Annie Peters
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 3, 2022
Utility of preclinical species for uncertainty assessment and correction of prediction of human volume of distribution using the Rodgers-Lukacova modelEva Sherbetjian, Sheila-Annie Peters, Carl Petersson
Current Opinion in Drug Discovery & Development|June 30, 2009
Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimizationSheila Annie Peters, Anna-Lena Ungell, Hugues Dolgos
Biopharmaceutics & Drug Disposition|February 3, 2017
A comparative evaluation of models to predict human intestinal metabolism from nonclinical dataEstelle Yau, Carl Petersson, Hugues Dolgos, et al.
Clinical Pharmacokinetics|February 8, 2023
Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?Jose David Gomez-Mantilla, Fenglei Huang, Sheila Annie Peters
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2012
Evaluation of the use of static and dynamic models to predict drug-drug interaction and its associated variability: impact on drug discovery and early developmentSheila Annie Peters, Patricia E Schroeder, Nagdeep Giri, et al.
Pageof 3